Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2)

TREM2 is an innate immune receptor specifically expressed in microglia. Coding variations in TREM2 have been reported to increase the risk for Alzheimer ’s disease (AD) and other neurodegenerative diseases. Whi...
Source: Molecular Neurodegeneration - Category: Neurology Authors: Tags: Research article Source Type: research
More News: Alzheimer's | Brain | Neurology